# NUDT15 c.415C>T increases risk of 6-mercaptopurine induced myelosuppression during maintenance therapy in children with acute lymphoblastic leukemia

## Metadata
**Authors:** Kanhatai Chiengthong, Chupong Ittiwut, Sasipa Muensri, Jiratchaya Sophonphan, Darintr Sosothikul, Panya Seksan, Koramit Suppipat, Kanya Suphapeetiporn, Vorasuk Shotelersuk
**Journal:** Haematologica
**Date:** 2016 Jan
**DOI:** [10.3324/haematol.2015.134775](https://doi.org/10.3324/haematol.2015.134775)
**PMID:** 26405151
**PMCID:** PMC4697903
**URL:** https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697903/
**PDF:** [https://pmc.ncbi.nlm.nih.gov/articles/PMC4697903/pdf/1010e24.pdf](https://pmc.ncbi.nlm.nih.gov/articles/PMC4697903/pdf/1010e24.pdf)

## Footnotes

## References

1. Hunger SP, Loh ML, Whitlock JA, et al. Children’s Oncology Group’s 2013 blueprint for research: acute lymphoblastic leukemia. Pediatr Blood Cancer. 2013;60(6):957–963.  [DOI](https://doi.org/10.1002/pbc.24420) | [PMC free article](/articles/PMC4045498/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/23255467/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Pediatr%20Blood%20Cancer&title=Children%E2%80%99s%20Oncology%20Group%E2%80%99s%202013%20blueprint%20for%20research:%20acute%20lymphoblastic%20leukemia&author=SP%20Hunger&author=ML%20Loh&author=JA%20Whitlock&volume=60&issue=6&publication_year=2013&pages=957-963&pmid=23255467&doi=10.1002/pbc.24420&)

2. Simone JV. The treatment of acute lymphoblastic leukaemia. Br J Haematol. 1980;45(1):1–4.  [DOI](https://doi.org/10.1111/j.1365-2141.1980.tb03804.x) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/6990965/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Br%20J%20Haematol&title=The%20treatment%20of%20acute%20lymphoblastic%20leukaemia&author=JV%20Simone&volume=45&issue=1&publication_year=1980&pages=1-4&pmid=6990965&doi=10.1111/j.1365-2141.1980.tb03804.x&)

3. Holland JF, Glidewell O. Chemotherapy of acute lymphocytic leukemia of childhood. Cancer. 1972;30(6):1480–1487.  [DOI](https://doi.org/10.1002/1097-0142(197212)30:6<1480::aid-cncr2820300611>3.0.co;2-3) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/4509104/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Cancer&title=Chemotherapy%20of%20acute%20lymphocytic%20leukemia%20of%20childhood&author=JF%20Holland&author=O%20Glidewell&volume=30&issue=6&publication_year=1972&pages=1480-1487&pmid=4509104&doi=10.1002/1097-0142(197212)30:6<1480::aid-cncr2820300611>3.0.co;2-3&)

4. Schmiegelow K, Nielsen SN, Frandsen TL, Nersting J. Mercaptopurine/Methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fiction. J Pediatr Hematol Oncol. 2014;36(7):503–517.  [DOI](https://doi.org/10.1097/MPH.0000000000000206) | [PMC free article](/articles/PMC4222610/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/24936744/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=J%20Pediatr%20Hematol%20Oncol&title=Mercaptopurine/Methotrexate%20maintenance%20therapy%20of%20childhood%20acute%20lymphoblastic%20leukemia:%20clinical%20facts%20and%20fiction&author=K%20Schmiegelow&author=SN%20Nielsen&author=TL%20Frandsen&author=J%20Nersting&volume=36&issue=7&publication_year=2014&pages=503-517&pmid=24936744&doi=10.1097/MPH.0000000000000206&)

5. Relling MV, Hancock ML, Boyett JM, Pui CH, Evans WE. Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia. Blood. 1999;93(9):2817–2823.  [PubMed](https://pubmed.ncbi.nlm.nih.gov/10216075/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Blood&title=Prognostic%20importance%20of%206-mercaptopurine%20dose%20intensity%20in%20acute%20lymphoblastic%20leukemia&author=MV%20Relling&author=ML%20Hancock&author=JM%20Boyett&author=CH%20Pui&author=WE%20Evans&volume=93&issue=9&publication_year=1999&pages=2817-2823&pmid=10216075&)

6. Lennard L. Implementation of TPMT testing. Br J Clin Pharmacol. 2014;77(4):704–714.  [DOI](https://doi.org/10.1111/bcp.12226) | [PMC free article](/articles/PMC3971986/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/23962279/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Br%20J%20Clin%20Pharmacol&title=Implementation%20of%20TPMT%20testing&author=L%20Lennard&volume=77&issue=4&publication_year=2014&pages=704-714&pmid=23962279&doi=10.1111/bcp.12226&)

7. Chang JG, Lee LS, Chen CM, et al. Molecular analysis of thiopurine S-methyltransferase alleles in South-east Asian populations. Pharmacogenetics. 2002;12(3):191–195.  [DOI](https://doi.org/10.1097/00008571-200204000-00003) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/11927834/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Pharmacogenetics&title=Molecular%20analysis%20of%20thiopurine%20S-methyltransferase%20alleles%20in%20South-east%20Asian%20populations&author=JG%20Chang&author=LS%20Lee&author=CM%20Chen&volume=12&issue=3&publication_year=2002&pages=191-195&pmid=11927834&doi=10.1097/00008571-200204000-00003&)

8. Srimartpirom S, Tassaneeyakul W, Kukongviriyapan V. Thiopurine S-methyltransferase genetic polymorphism in the Thai population. Br J Clin Pharmacol. 2004;58(1):66–70.  [DOI](https://doi.org/10.1111/j.1365-2125.2004.02112.x) | [PMC free article](/articles/PMC1884540/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/15206995/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Br%20J%20Clin%20Pharmacol&title=Thiopurine%20S-methyltransferase%20genetic%20polymorphism%20in%20the%20Thai%20population&author=S%20Srimartpirom&author=W%20Tassaneeyakul&author=V%20Kukongviriyapan&volume=58&issue=1&publication_year=2004&pages=66-70&pmid=15206995&doi=10.1111/j.1365-2125.2004.02112.x&)

9. Vannaprasaht S, Angsuthum S, Avihingsanon Y, et al. Impact of the heterozygous TPMT*1/*3C genotype on azathioprine-induced myelosuppression in kidney transplant recipients in Thailand. Clin Ther. 2009;31(7):1524–1533.  [DOI](https://doi.org/10.1016/j.clinthera.2009.07.008) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/19695401/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Clin%20Ther&title=Impact%20of%20the%20heterozygous%20TPMT*1/*3C%20genotype%20on%20azathioprine-induced%20myelosuppression%20in%20kidney%20transplant%20recipients%20in%20Thailand&author=S%20Vannaprasaht&author=S%20Angsuthum&author=Y%20Avihingsanon&volume=31&issue=7&publication_year=2009&pages=1524-1533&pmid=19695401&doi=10.1016/j.clinthera.2009.07.008&)

10. Wan Rosalina WR, Teh LK, Mohamad N, et al. Polymorphism of ITPA 94C>A and risk of adverse effects among patients with acute lymphoblastic leukaemia treated with 6-mercaptopurine. J Clin Pharm Ther. 2012;37(2):237–241.  [DOI](https://doi.org/10.1111/j.1365-2710.2011.01272.x) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/21545474/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Pharm%20Ther&title=Polymorphism%20of%20ITPA%2094C>A%20and%20risk%20of%20adverse%20effects%20among%20patients%20with%20acute%20lymphoblastic%20leukaemia%20treated%20with%206-mercaptopurine&author=WR%20Wan%20Rosalina&author=LK%20Teh&author=N%20Mohamad&volume=37&issue=2&publication_year=2012&pages=237-241&pmid=21545474&doi=10.1111/j.1365-2710.2011.01272.x&)

11. Tanaka Y, Manabe A, Nakadate H, et al. The activity of the inosine triphosphate pyrophosphatase affects toxicity of 6-mercaptopurine during maintenance therapy for acute lymphoblastic leukemia in Japanese children. Leuk Res. 2012;36(5):560–564.  [DOI](https://doi.org/10.1016/j.leukres.2011.11.015) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/22200619/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Leuk%20Res&title=The%20activity%20of%20the%20inosine%20triphosphate%20pyrophosphatase%20affects%20toxicity%20of%206-mercaptopurine%20during%20maintenance%20therapy%20for%20acute%20lymphoblastic%20leukemia%20in%20Japanese%20children&author=Y%20Tanaka&author=A%20Manabe&author=H%20Nakadate&volume=36&issue=5&publication_year=2012&pages=560-564&pmid=22200619&doi=10.1016/j.leukres.2011.11.015&)

12. Yang SK, Hong M, Baek J, et al. A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia. Nat Genet. 2014;46(9):1017–1020.  [DOI](https://doi.org/10.1038/ng.3060) | [PMC free article](/articles/PMC4999337/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/25108385/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Nat%20Genet&title=A%20common%20missense%20variant%20in%20NUDT15%20confers%20susceptibility%20to%20thiopurine-induced%20leukopenia&author=SK%20Yang&author=M%20Hong&author=J%20Baek&volume=46&issue=9&publication_year=2014&pages=1017-1020&pmid=25108385&doi=10.1038/ng.3060&)

13. Yang JJ, Landier W, Yang W, et al. Inherited NUDT15 Variant Is a Genetic Determinant of Mercaptopurine Intolerance in Children With Acute Lymphoblastic Leukemia. J Clin Oncol. 2015; 33(11):1235–1242.  [DOI](https://doi.org/10.1200/JCO.2014.59.4671) | [PMC free article](/articles/PMC4375304/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/25624441/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&title=Inherited%20NUDT15%20Variant%20Is%20a%20Genetic%20Determinant%20of%20Mercaptopurine%20Intolerance%20in%20Children%20With%20Acute%20Lymphoblastic%20Leukemia&author=JJ%20Yang&author=W%20Landier&author=W%20Yang&volume=33&issue=11&publication_year=2015&pages=1235-1242&pmid=25624441&doi=10.1200/JCO.2014.59.4671&)

14. Tanaka Y, Kato M, Hasegawa D, et al. Susceptibility to 6-MP toxicity conferred by a NUDT15 variant in Japanese children with acute lymphoblastic leukemia. Br J Haematol. 2015;171(1):109–115.  [DOI](https://doi.org/10.1111/bjh.13518) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/26033531/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Br%20J%20Haematol&title=Susceptibility%20to%206-MP%20toxicity%20conferred%20by%20a%20NUDT15%20variant%20in%20Japanese%20children%20with%20acute%20lymphoblastic%20leukemia&author=Y%20Tanaka&author=M%20Kato&author=D%20Hasegawa&volume=171&issue=1&publication_year=2015&pages=109-115&pmid=26033531&doi=10.1111/bjh.13518&)

15. Kanjanapongkul S. Outcome of acute lymphoblastic leukemia treatment using national protocols at the Queen Sirikit National Institute of Child Health. J Med Assoc Thai. 2014;97(6):S1–5.  [PubMed](https://pubmed.ncbi.nlm.nih.gov/25391165/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=J%20Med%20Assoc%20Thai&title=Outcome%20of%20acute%20lymphoblastic%20leukemia%20treatment%20using%20national%20protocols%20at%20the%20Queen%20Sirikit%20National%20Institute%20of%20Child%20Health&author=S%20Kanjanapongkul&volume=97&issue=6&publication_year=2014&pages=S1-5&pmid=25391165&)
